Myriad Genetics, Inc. Reports Results For Second Quarter Of Fiscal 2007

February 6, 2007 |

1 min read

SALT LAKE CITY, UT -- (MARKET WIRE) -- February 06, 2007 -- Myriad Genetics, Inc. (NASDAQ: MYGN) today reported financial results for the second quarter of fiscal 2007 and the six months ended December 31, 2006.

Earnings

MORE ON THIS TOPIC

Podcast

CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP

July 2, 2025

·

1 min read

·

Heather McKenzie

A contemporary artistic collage depicting a hand holding pills, passing them to another hand. The concept of medication and treatment.

Collaboration

Argenx Makes $1.5B+ Play for UNP’s Macrocyclic Peptides Aimed at ‘Undruggable’ Targets

July 1, 2025

·

2 min read

·

Tristan Manalac

Contemporary art collage, female palms in the orange circle, a bag of money. Concept of business and finance.

Mergers & acquisitions

AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies

June 30, 2025

·

2 min read

·

Dan Samorodnitsky

Illustration showing businessman bringing personal items in box stock

Layoffs

BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900

June 30, 2025

·

1 min read

·